Longevity business driven by public health gains in US

Public health, explained: Sign up to receive Dr. Jay K. Varma’s reports in your inbox a day early. Hello and welcome to Healthbeat’s weekly report on the stories shaping public health in the United States. I am Dr. Jay K. Varma, a physician, epidemiologist, and public health expert currently serving as chief medical officer at Fedcap, a national nonprofit focused on economic mobility and well-being for vulnerable communities. The views expressed here are my own. This week, I’m focusing on one of the hottest topics in U.S. health care: longevity. Much of today’s longevity industry focuses on expensive medical interventions, even though the largest gains in life expectancy have come from public health and social conditions. Longevity is now a big business I am increasingly bombarded with advertisements for pills, scans, and tests that can help me live a longer and healthier life. The way these are marketed and the absence of high-quality evidence for their benefit indicate that these ven